Investing.com – Curevac Company BV (NASDAQ: ) Q3 Report Beats Analysts’ Estimates with income lower than expected figures According to information released on Tuesday.
Curevac BV’s earnings per share (EPS) were €-0.22 on revenue of €16.5M. Analyst opinions compiled by Investing.com Expectations for the upcoming forecast: Previously, the figure was thought to be €-0.23 per share on revenue of €16.97M.
In addition to CureVac BV, there are other companies. in the healthcare sector of the NASDAQ stock market Markets reporting earnings this month
Eli Lilly previously reported Q3 earnings of €0.1 per share on revenue of €9.5B, versus expectations of €-0.2 on revenue of €8.97B.
Novo Nordisk ADR’s latest reported performance beat analyst forecasts. Q3 earnings came in at €5 per share on revenue of €58.73B, compared with analysts’ estimates. Investing.com EPS is expected to be around €0.6751 on revenue of €8.16B.
Follow the latest developments in the company’s profits via Investing.com Earnings Calendar
2023-11-15 12:27:36
#CureVac #profit #beats #expectations #revenue #falls #short #expectations #Investing.com
